AVEO Pharmaceuticals (AVEO) Reports Q2 Loss, Lags Revenue Estimates

AVEO Pharmaceuticals (AVEO) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to loss of $0.20 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 17.65%. A quarter ago, it was expected that this cancer drug company would post a loss of $0.50 per share when it actually produced a loss of $0.52, delivering a surprise of -4%.
Over the last four quar…

Click here to view the original article.